Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors
Clinical trial NCT03382834 · COMPLETED
Trial details
- NCT number
- NCT03382834
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2018-12-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.